Author

Timi Martelius

University of HelsinkiPrimary ORCID profile (0000-0002-3678-958X · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Timi MarteliusiD1 paper · University of Helsinki

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:CRISPR screen· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Anniken Solveig Matheson Sollano· 1 shared Børre FevangiD· 1 shared Camilla Schalin-Jäntti· 1 shared Eira LeinoneniD· 1 shared Eliisa KekäläineniD· 1 shared Emma Maria HaapaniemiiD· 1 shared Juha GrönholmiD· 1 shared Katariina MamiaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Anniken Solveig Matheson Sollano

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Protocol for Non-viral HDR-based CRISPR/Cas9 platform for small custom editing in primary T cells

Katariina Mamia, Anniken Solveig Matheson Sollano, Vanja Lundberg, Svetlana Vakkilainen, Eliisa Kekäläinen, Camilla Schalin-Jäntti, Eira Leinonen, Børre Fevang, Juha Grönholm, Timi Martelius, Shiva Dahal‐Koirala, Emma Maria Haapaniemi

This paper presents a non-viral HDR-based CRISPR/Cas9 protocol for editing primary T cells with up to 80% HDR efficiency, targeting small pathogenic variants in patient and healthy donor cells.

Frontiers in Genome Editing · Sep 30, 2026Peer-reviewedMolecular Biology